Germany · Venture startup

Who invested in HepaRegeniX

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$34Mraised across 2 rounds since 2017, from 2 sources

$9.5MSeries A$24MVenture
Latest round
Venture, $24MApr 2025
Step-upi
2.6×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172019202120232025
$9.5MSeries A$24MVenture
First round
Series A, $9.5M
Jan 2017
Biggest round
$24M
Venture · Apr 2025
Between rounds
8.3 years
from the last two

The rounds

  1. Apr 2025
  2. Jan 2017
    Series A$9.5M2 new

    Reported by FinSMEs

Founders and team

From HepaRegeniX's own website: 13 on the team.

  • Elias PapatheodorouChief Executive Officer
  • Christoph EnderleChief Financial Officer
  • Dr. Linda GreenbaumChief Medical Officer
  • Dr. Wolfgang AlbrechtChief Operating Officer
  • Dr. Emmanuelle CoutanceauBoard Member / Novo Holdings A/S
  • Dr. Fabienne RousselBoard Member / Vesalius Biocapital
  • Dr. Frank HenselBoard Member / High-Tech Gründerfonds (HTGF)
  • Dr. Manuel BaaderBoard Member / Boehringer Ingelheim Venture Fund
  • Dr. Martin BondeChair of the Board
  • Dr. Roland SeligLead Medicinal and Process Chemistry
  • Dr. Tillmann TaubeSenior Medical Director
  • Hedda WoldLead Clinical Operations
  • Stefan ZwirnerLead In vitro Pharmacology

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Novo HoldingsVC firm1round
Wellington PartnersVC firm1round
Novo SeedsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about HepaRegeniX

Who invested in HepaRegeniX?

HepaRegeniX's investors include Novo Holdings, Wellington Partners, Boehringer Ingelheim Venture Fund, Boehringer Ingelheim and Novo Seeds.

How much has HepaRegeniX raised?

HepaRegeniX has raised $34M across 2 rounds since 2017.

When did HepaRegeniX last raise?

HepaRegeniX's most recent round was a Venture of $24M in Apr 2025.

What was HepaRegeniX's biggest round?

Its most recent round, $24M in Apr 2025, is also its largest on record.

Who backed HepaRegeniX first?

HepaRegeniX's first round on record, in Jan 2017, was backed by Boehringer Ingelheim and Novo Seeds.

What stage is HepaRegeniX at?

HepaRegeniX's latest named round is a Venture, in Apr 2025.

Where is HepaRegeniX based?

HepaRegeniX is based in Germany.

Companies like HepaRegeniX

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.